80 related articles for article (PubMed ID: 20220747)
1. Pharmacokinetic and pharmacodynamic interactions between the immunosuppressant sirolimus and the lipid-lowering drug ezetimibe in healthy volunteers.
Oswald S; Nassif A; Modess C; Keiser M; Hanke U; Engel A; Lütjohann D; Weitschies W; Siegmund W
Clin Pharmacol Ther; 2010 Jun; 87(6):663-7. PubMed ID: 20220747
[TBL] [Abstract][Full Text] [Related]
2. Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers.
Oswald S; Nassif A; Modess C; Keiser M; Ulrich A; Runge D; Hanke U; Lütjohann D; Engel A; Weitschies W; Siegmund W
Clin Pharmacol Ther; 2011 Apr; 89(4):524-8. PubMed ID: 21368751
[TBL] [Abstract][Full Text] [Related]
3. Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteers.
Oswald S; Meyer zu Schwabedissen HE; Nassif A; Modess C; Desta Z; Ogburn ET; Mostertz J; Keiser M; Jia J; Hubeny A; Ulrich A; Runge D; Marinova M; Lütjohann D; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2012 Mar; 91(3):506-13. PubMed ID: 22297387
[TBL] [Abstract][Full Text] [Related]
4. Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
Oswald S; König J; Lütjohann D; Giessmann T; Kroemer HK; Rimmbach C; Rosskopf D; Fromm MF; Siegmund W
Pharmacogenet Genomics; 2008 Jul; 18(7):559-68. PubMed ID: 18551036
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers.
Reyderman L; Kosoglou T; Boutros T; Seiberling M; Statkevich P
Curr Med Res Opin; 2004 Sep; 20(9):1493-500. PubMed ID: 15383199
[TBL] [Abstract][Full Text] [Related]
6. Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin.
Kosoglou T; Statkevich P; Meyer I; Cutler DL; Musiol B; Yang B; Zhu Y; Maxwell SE; Veltri EP
Curr Med Res Opin; 2004 Jun; 20(6):955-65. PubMed ID: 15200755
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
[TBL] [Abstract][Full Text] [Related]
8. Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
Bergman AJ; Burke J; Larson P; Johnson-Levonas AO; Reyderman L; Statkevich P; Kosoglou T; Greenberg HE; Kraft WK; Frick G; Murphy G; Gottesdiener K; Paolini JF
J Clin Pharmacol; 2006 Mar; 46(3):321-7. PubMed ID: 16490808
[TBL] [Abstract][Full Text] [Related]
9. Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients.
Bergman AJ; Burke J; Larson P; Johnson-Levonas AO; Reyderman L; Statkevich P; Maxwell SE; Kosoglou T; Murphy G; Gottesdiener K; Robson R; Paolini JF
J Clin Pharmacol; 2006 Mar; 46(3):328-36. PubMed ID: 16490809
[TBL] [Abstract][Full Text] [Related]
10. Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins.
Oswald S; Giessmann T; Luetjohann D; Wegner D; Rosskopf D; Weitschies W; Siegmund W
Clin Pharmacol Ther; 2006 Nov; 80(5):477-85. PubMed ID: 17112804
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of sirolimus in Thai healthy volunteers.
Leelahavanichkul A; Areepium N; Vadcharavivad S; Praditpornsilpa K; Avihingsanon Y; Karnjanabuchmd T; Eiam-Ong S; Tungsanga K
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S157-62. PubMed ID: 16623021
[TBL] [Abstract][Full Text] [Related]
12. Synergistic influence of Abcb1 and Abcc2 on disposition and sterol lowering effects of ezetimibe in rats.
Oswald S; May K; Rosin J; Lütjohann D; Siegmund W
J Pharm Sci; 2010 Jan; 99(1):422-9. PubMed ID: 19504475
[TBL] [Abstract][Full Text] [Related]
13. The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.
Reyderman L; Kosoglou T; Cutler DL; Maxwell S; Statkevich P
Curr Med Res Opin; 2005 Aug; 21(8):1171-9. PubMed ID: 16083526
[TBL] [Abstract][Full Text] [Related]
14. Supratherapeutic response to ezetimibe administered with cyclosporine.
Koshman SL; Lalonde LD; Burton I; Tymchak WJ; Pearson GJ
Ann Pharmacother; 2005 Sep; 39(9):1561-5. PubMed ID: 16030077
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients.
Budde K; Neumayer HH; Lehne G; Winkler M; Hauser IA; Lison A; Fritsche L; Soulillou JP; Fauchald P; Dantal J;
Nephrol Dial Transplant; 2004 Oct; 19(10):2606-14. PubMed ID: 15316094
[TBL] [Abstract][Full Text] [Related]
16. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
Catapano A; Brady WE; King TR; Palmisano J
Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
[TBL] [Abstract][Full Text] [Related]
17. Utility of ezetimibe.
Ashikaga H; Blumenthal RS; Jones SR
Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
[No Abstract] [Full Text] [Related]
18. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
Bali V; Ali M; Ali J
J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of ezetimibe.
Simard C; Turgeon J
Can J Clin Pharmacol; 2003; 10 Suppl A():13A-20A. PubMed ID: 14571304
[TBL] [Abstract][Full Text] [Related]
20. Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells.
Kopplow K; Letschert K; König J; Walter B; Keppler D
Mol Pharmacol; 2005 Oct; 68(4):1031-8. PubMed ID: 16046661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
